Editors' Note: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
Neurology. 2022 Aug 9;99(6):258. doi: 10.1212/WNL.0000000000201001.
Neurology. 2022.
PMID: 35940889
No abstract available.